Using imaging to guide blood thinner use after a heart attack
Part of Heart & circulation clinical trials.
This study tests if doctors can safely use special eye scans (OCT) or angiography to decide when to stop taking two blood thinners (DAPT) after a heart attack and stent placement. It aims to reduce bleeding risks while still protecting your heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You had a heart attack (STEMI) and got a stent placed.
- You are willing to take part in the study and follow its rules.
- You do not have a history of bleeding in the brain or stroke in the last 6 months.
- You are not allergic to aspirin or the blood thinners clopidogrel or ticagrelor.
- You are not taking long-term blood thinners (like warfarin) or have a major bleeding risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a shorter course of two blood thinners, guided by an ultrasound inside the arteries, is as safe and effective as the standard longer course in people who have had a stent placed for a heart attack or chest pain.
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
This trial compares two ways to guide treatment during a heart attack: using a special camera (OCT) inside the artery or standard X-ray (angiography). It aims to see which method leads to better results for patients.
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
This study tests whether a personalized score (OPT-CAD) can help decide the best time to stop or reduce blood-thinning medication in people who have had a heart attack and a stent placed. It aims to balance preventing future heart issues while lowering the risk of bleeding.
This trial tests if a shorter, lower dose of two blood thinners is safe and effective for patients with a recent heart attack or unstable angina who are at high risk for bleeding. It uses a special stent that might allow for less medication.
Hear when a new Optical Coherence Tomography trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.